Pharmafile.com’s weekly COVID-19 news round-up
July 1, 2020Research and Development COVID-19, coronavirus
COVID-19 vaccines dominate this week’s news cycle, with Vaxart announcing the selection of its lead candidate for COVID-19 by Operation …
US buys most of the world’s stock of COVID-19 drug remdesivir
July 1, 2020Research and Development COVID-19, coronavirus
The US has bought most of the world’s stock of the drug remdesivir which is one of the only drugs …
FDA says COVID-19 vaccine would need to be at least 50% effective to be approved
July 1, 2020Research and Development COVID-19, FDA, coronavirus
The FDA announced that any COVID-19 vaccine that gets approval must show that it is at least 50% more effective …
India to go ahead with human trials of COVID-19 vaccine in July
June 30, 2020Manufacturing and Production COVID-19, Vaccine, coronavirus
A trial of a new Indian made vaccine will begin testing in humans from July. The vaccine is called Covaxin …
Roche’s Phesgo combo secures US approval for metastatic HER2-positive breast cancer
June 30, 2020Manufacturing and Production, Sales and Marketing FDA, Phesgo, Roche, US, breast cancer
The FDA has awarded marketing authorisation in the US to Roche’s Phesgo, a combination of subcutaneously injected Herceptin (trastuzumab) with …
New swine flu with pandemic potential identified in China
June 30, 2020Manufacturing and Production flu, flu pandemic, swine flu
A new strain of flu has emerged in pigs in China, with scientists warning it has pandemic potential. Researchers call …
The July/August 2020 issue of Pharmafocus is available to read free online now!
June 30, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, Pharmafocus, pharma
The July/August 2020 issue of Pharmafocus is available to read free online now!
Gilead facing criticism for charging $2,340 for remdesivir
June 30, 2020Manufacturing and Production COVID-19, coronavirus
Gilead has announced that it will charge $2,340 for a 5 day treatment course of remdesivir, a drug that has …
NICE knocks back Janssen’s Zytiga combo for newly diagnosed, hormone-sensitive metastatic prostate cancer.
June 29, 2020Sales and Marketing
Drug watchdog NICE has chosen to stick with its earlier decision not to recommend Janssen’s Zytiga (abiraterone aetate), combined with …
FDA rejects Allergan’s Abicipar pegol for neovascular age-related macular degeneration over benefit/risk concerns
June 29, 2020Sales and Marketing AbbVie, Allergan, FDA, pharma
The FDA has moved to reject Allergan’s vascular endothelial growth factor (VEGF) factor A inhibitor, Abicipar pegol, as treatment for …
Vaxart announces its COVID-19 vaccine has been selected by US Operation Warp Speed programme
June 29, 2020Sales and Marketing COVID-19, COVID-19 vaccine, coronavirus, coronavirus vaccine
Vaxart has announced the selection of its lead vaccine candidate for COVID-19 by Operation Warp Speed, a program to find …
China’s COVID-19 vaccine candidate approved for military use
June 29, 2020Sales and Marketing COVID-19, coronavirus
China’s military have received approval to use a new vaccine candidate for coronavirus after clinical trials proved it was safe …
Pfizer sues US for permission to help Medicare patients with rare heart conditions
June 29, 2020Sales and Marketing Medicaid, Medicare, Pfizer
Pfizer has filed a lawsuit against the US government to allow it to directly help with the copayments of Medicare …
NICE to recommend Roche cancer treatment
June 26, 2020Medical Communications NHS, NICE
NICE are set to recommend Roche’s Rozlytrek (Entrectinib) cancer treatment which will be the second histology drug to be recommended …
Novartis agrees to pay $347 million to settle bribery allegations
June 26, 2020Medical Communications Greece, Novartis, bribery
Novartis and its former eye care unit Alcon have agreed to pay a combined $347 million to resolve allegations that …
70% of BAME pharmacists in the UK have had no risk assessment for COVID-19
June 26, 2020Medical Communications COVID-19, coronavirus
More than two thirds of black, Asian and minority ethnic pharmacists have not had any workplace risk assessments for COVID-19, …
Gilead’s remdesivir becomes first EU-recommended therapy for COVID-19
June 26, 2020Medical Communications, Sales and Marketing COVID-19, EU Gilead, remdesivir
In a crucial step amidst the ongoing pandemic, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) …
Top Ten most popular articles on Pharmafile.com this week
June 26, 2020Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, coronavirus, top 10
The news this week centres on the pandemic in Europe, with the Independent SAGE group are warning that it is …
AstraZeneca continues to ramp up COVID-19 vaccine production with new CMO partnership
June 25, 2020Manufacturing and Production AstraZeneca, COVID-19, Vaccine
AstraZeneca has continued to build its manufacturing capacity to deliver its COVID-19 vaccine candidate, developed in partnership with the University …
NICE knocks back Novartis’ Mayzent in secondary progressive multiple sclerosis over data gaps
June 25, 2020Sales and Marketing Mayzent, NHS, NICE, Novartis
Novartis’ Mayzent (siponimod) has been unsuccessful in securing a recommendation from NICE for use on the NHS for the treatment …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
